mdlinx mdlinx
Urology Articles on MDLinx
Latest (18) Full Text Top Read since last login Article Summary

Goserelin versus leuprolide in the chemical castration of patients with prostate cancer
International Urology and Nephrology, 02/14/2012  Clinical Article

Silva ED et al. – There were no statistically significant differences in the levels of castration when comparing leuprolide 3.75 mg, leuprolide 7.5 mg, and goserelin 3.6 mg, altogether. The importance of this difference, however, must be measured with caution, since the comparison of the three groups simultaneously did not reach the established significance level, even though it came close.

Read this article in International Urology and Nephrology read MDLinx article: Goserelin versus leuprolide in the chemical castration of patients with prostate cancer

<< Previous Article | Next Article >>
Get reports via email to claim your reading activity at MDLinx as Category 2 CME (It takes less than a minute)

Your Unread Messages in Urology

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Urology Articles

Last month's top read Top 50 of 2011

Indexed Journals in Urology: Urology, Journal of Urology, European Urology, The Prostatemore

Other Topics in Urology

Stay current - Media Tool

Newsletter
RSS
Follow Us
Facebook

Edit My Newsletter Settings

Receive free subspecialty
"5-minute updates" via email

Sign up!

Send the E-mail Newsletter to a Colleague


Send

Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More

Close